Sareum’s strategy is to develop programmes to late preclinical or early clinical stages to take advantage of the higher asset values associated with licensing programmes at these stages.
Approach |
Benefit |
Pursue multiple programmes |
|
Seek collaboration partners |
|
Develop programmes to pre-clinical/ |
|